NCT05285254

Brief Summary

The purpose of this study is to provide the first systematic evidence that Certified Child Life Specialists reduce pain during vaccine administration and improve caregiver visit satisfaction in the pediatric primary care setting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P75+ for not_applicable pain

Timeline
Completed

Started Jun 2021

Shorter than P25 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 28, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 8, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 17, 2022

Completed
Last Updated

March 17, 2022

Status Verified

March 1, 2022

Enrollment Period

1 month

First QC Date

March 8, 2022

Last Update Submit

March 8, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Patient-reported pain

    Measured using the Faces Pain Scale-Revised (FPS-R). This is a self-report measure of pain validated for children ages 4-16 years of age and approved for the assessment of pediatric pain at Mayo Clinic. The scale utilizes different faces to score the sensation of pain on a 0-to-10 metric.

    Post vaccine administration, approximately 1 hour

  • Observed Negative Emotional Responses

    Measured using the Children's Emotional Manifestation Scale (CEMS). The CEMS consists of five categories (facial expression, vocalization, activity, interaction, and level of cooperation) with each category scored from 1 to 5, with summed scores from 5 to 25. Higher scores represent more negative emotional behaviors. The scale was initially validated for children 7-12 years of age but has been subsequently used by other studies for children as young as 4 years of age.

    Post vaccine administration, approximately 1 hour

Secondary Outcomes (1)

  • Caregiver visit satisfaction

    Post vaccine administration, approximately 1 hour

Study Arms (2)

Immunization Administration with Certified Child Life Specialist Support (CCLS)

EXPERIMENTAL

Nursing will administer immunizations to children with the support of a CCLS

Other: Certified Child Life Specialist Support

Current Standard of Care for Immunization Administration

NO INTERVENTION

Nursing will administer immunizations to children per their current standard of care.

Interventions

Provides psychosocial care to children and families confronting stressful and painful situations

Immunization Administration with Certified Child Life Specialist Support (CCLS)

Eligibility Criteria

Age4 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children 4-12 years of age presenting to MCHS Red Wing for a well child examination and vaccine administration.
  • Parents or caregivers of any age presenting to well child examination with child.
  • Legal guardians of all participants must provide verbal consent.
  • Patients must provide verbal assent for participation.Verbal assent will be waived for children younger than 6 years.

You may not qualify if:

  • Children with autism or other severe developmental disabilities.
  • Children must be able to communicate pain before and after vaccine administration using the FPS-R.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic Health System - Red Wing

Red Wing, Minnesota, 55066, United States

Location

Related Links

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Seth Gregory, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 8, 2022

First Posted

March 17, 2022

Study Start

June 28, 2021

Primary Completion

July 30, 2021

Study Completion

July 30, 2021

Last Updated

March 17, 2022

Record last verified: 2022-03

Locations